Lipid Alterations in Systemic Sclerosis

Background: Systemic sclerosis (SSc) is an autoimmune disease with an elusive etiology and poor prognosis. Due to its diverse clinical presentation, a personalized approach is obligatory and needs to be based on a comprehensive biomarker panel. Therefore, particular metabolomic studies are necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogulska, Zuzanna, Smolenska, Zaneta, Turyn, Jacek, Mika, Adriana, Zdrojewski, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724564/
https://www.ncbi.nlm.nih.gov/pubmed/34993231
http://dx.doi.org/10.3389/fmolb.2021.761721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724564/
https://www.ncbi.nlm.nih.gov/pubmed/34993231
http://dx.doi.org/10.3389/fmolb.2021.761721

Ejemplares similares